These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1289350)

  • 1. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp.
    O'Hare MD; Reynolds PE
    J Antimicrob Chemother; 1992 Dec; 30(6):753-68. PubMed ID: 1289350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.
    Sieradzki K; Villari P; Tomasz A
    Antimicrob Agents Chemother; 1998 Jan; 42(1):100-7. PubMed ID: 9449268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
    Goldstein FW; Coutrot A; Sieffer A; Acar JF
    Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopeptide resistance in coagulase-negative staphylococci.
    Biavasco F; Vignaroli C; Varaldo PE
    Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis.
    Sanyal D; Greenwood D
    J Med Microbiol; 1993 Sep; 39(3):204-10. PubMed ID: 8366519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
    Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
    Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.
    Sanyal D; Johnson AP; George RC; Edwards R; Greenwood D
    J Antimicrob Chemother; 1993 Aug; 32(2):267-78. PubMed ID: 8226428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
    Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
    J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    Biavasco F; Giovanetti E; Montanari MP; Lupidi R; Varaldo PE
    J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
    Biavasco F; Vignaroli C; Lazzarini R; Varaldo PE
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
    Jean-Pierre H; Rivière M; Darbas H; Boyer G
    Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
    Tabe Y; Nakamura A; Igari J
    J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F; Bingen E; Lambert-Zechovsky N
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
    Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
    Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
    Low DE; McGeer A; Poon R
    Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics.
    Billot-Klein D; Gutmann L; Bryant D; Bell D; Van Heijenoort J; Grewal J; Shlaes DM
    J Bacteriol; 1996 Aug; 178(15):4696-703. PubMed ID: 8755902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of glycopeptide antibiotics against coagulase-negative staphylococci embedded in fibrin clots.
    Cunningham R; Cheesbrough J
    J Antimicrob Chemother; 1992 Sep; 30(3):321-6. PubMed ID: 1452497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.